诚意药业(603811.SH)：累计回购2.94%股份 回购计划实施完毕

Summary of Key Points Core Viewpoint - Chengyi Pharmaceutical (603811.SH) has completed its share repurchase plan, reaching the lower limit of the repurchase amount as of the announcement date [1] Group 1: Share Repurchase Details - The company has repurchased a total of 9,618,796 shares through centralized bidding, which accounts for 2.94% of the total share capital [1] - The highest transaction price was 8.36 CNY per share, while the lowest was 7.25 CNY per share, with an average transaction price of 7.94 CNY per share [1] - The total amount paid for the repurchased shares was 76,397,831.64 CNY, excluding transaction fees [1]